{
  "trial_id": "NCT04815421",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "aged from 14 to 60 years",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "No other therapy before grouped",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Be willing to participate the study and sign the informed consent",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "The onset of symptoms and signs are less than 24 hours",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Male or female aged from 14 to 60 years",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "spondylosis",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "Suffered from systemic collagen immune diseases or other acute or chronic infection",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "Use pain-killer drugs may affect the outcome evaluation",
      "label": "not_met",
      "evidence": "unknown"
    }
  ],
  "notes": "62-year-old African-American man with left upper and lower extremity weakness, dark visual spot in right eye, facial numbness, facial drop, slurred speech. Hypertension, hyperlipidemia, hypothyroidism, smoker, alcohol consumption.",
  "_meta": {
    "topic_id": "47",
    "trial_id": "NCT04815421",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}